Meanwhile, edaravone treatment has been shown to activate Nrf2, heme oxygenase 1, and SIRT1 in experimental models of traumatic brain injury, amyotrophic lateral sclerosis, and stroke (Ismail et al., 2020; Cui X. et al., 2022). Here, NFE2L2 is linked to brain injury.